01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/2025

Jan 12, 2025, 10:52 | Science
Myeloma Paper of the Day, January 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Retrospective review of end-stage…
Jan 12, 2025, 09:13 | Blog
Shaban Juma: The importance of HPV vaccination and early screening for pre-malignant lesions
Shaban Juma, Resident in Clinical Oncology at Muhimbili University of Health and Allied Sciences, shared…
Jan 12, 2025, 09:05 | Blog
Examining the prevalence and risk factors of metabolic syndrome among adult survivors of childhood cancer
ACS Journal Cancer shared on X: "A new editorial from Aman Wadhwa responds to recent…
Jan 12, 2025, 08:51 | Blog
Eribulin + HP as first-line treatment of locally advanced/metastatic HER2+ breast cancer
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Trastuzumab-Pertuzumab Plus…
Jan 12, 2025, 08:44 | Blog
Isabel Preeshagul: Addressing barriers to clinical trial accrual in patients with lung cancer
Isabel Preeshagul, Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center, shared on X: "PATIENTS…
Jan 12, 2025, 08:00 | Blog
Implementation of AI for cancer detection in population-based mammography screening
Yüksel Ürün shared on X: "AI is HERE! In mammography screening, AI-supported double reading detects…
Jan 12, 2025, 07:53 | Blog
Ponsegromab as a novel, targeted therapy to address unmet needs of patients with cancer and cachexia
ACS Journal Cancer shared on X: "In the latest Cancer Scope, attention is given to…
Jan 12, 2025, 07:18 | Blog
Northern Ireland is now among the first places in the world to estimate how many people are living secondary breast cancer
Ann McBrien, Former NHS accountant Metastatic breast cancer patient, committed to cancer research and delivering…
Jan 12, 2025, 07:12 | Insight
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer
Pfizer Inc. has announced promising topline results from its pivotal Phase 3 CREST trial, which…
Jan 12, 2025, 07:07 | Insight
Elvina Almuradova: ctDNA/MRD testing shows promise in guiding colon cancer treatment
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
All: 2689 Posts: 1911 - 1920
Special Coverage